Literature DB >> 29590401

Noradrenergic Activity in the Human Brain: A Mechanism Supporting the Defense Against Hypoglycemia.

Renata Belfort-DeAguiar1, Jean-Dominique Gallezot2, Janice J Hwang1, Ahmed Elshafie1, Catherine W Yeckel3, Owen Chan4, Richard E Carson2, Yu-Shin Ding5, Robert S Sherwin1.   

Abstract

Context: Hypoglycemia, one of the major factors limiting optimal glycemic control in insulin-treated patients with diabetes, elicits a brain response to restore normoglycemia by activating counterregulation. Animal data indicate that local release of norepinephrine (NE) in the hypothalamus is important for triggering hypoglycemia-induced counterregulatory (CR) hormonal responses. Objective: To examine the potential role of brain noradrenergic (NA) activation in humans during hypoglycemia. Design: A hyperinsulinemic-hypoglycemic clamp was performed in conjunction with positron emission tomographic imaging. Participants: Nine lean healthy volunteers were studied during the hyperinsulinemic-hypoglycemic clamp. Design: Participants received intravenous injections of (S,S)-[11C]O-methylreboxetine ([11C]MRB), a highly selective NE transporter (NET) ligand, at baseline and during hypoglycemia.
Results: Hypoglycemia increased plasma epinephrine, glucagon, cortisol, and growth hormone and decreased [11C]MRB binding potential (BPND) by 24% ± 12% in the raphe nucleus (P < 0.01). In contrast, changes in [11C]MRB BPND in the hypothalamus positively correlated with increments in epinephrine and glucagon levels and negatively correlated with glucose infusion rate (all P < 0.05). Furthermore, in rat hypothalamus studies, hypoglycemia induced NET translocation from the cytosol to the plasma membrane. Conclusions: Insulin-induced hypoglycemia initiated a complex brain NA response in humans. Raphe nuclei, a region involved in regulating autonomic output, motor activity, and hunger, had increased NA activity, whereas the hypothalamus showed a NET-binding pattern that was associated with the individual's CR response magnitude. These findings suggest that NA output most likely is important for modulating brain responses to hypoglycemia in humans.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29590401      PMCID: PMC6456998          DOI: 10.1210/jc.2017-02717

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

Review 1.  Central Mechanisms of Glucose Sensing and Counterregulation in Defense of Hypoglycemia.

Authors:  Sarah Stanley; Amir Moheet; Elizabeth R Seaquist
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

2.  Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.

Authors:  David S Goldstein; Patti Sullivan; Courtney Holmes; Guillaume Lamotte; Abhishek Lenka; Yehonatan Sharabi
Journal:  J Neurochem       Date:  2021-05-21       Impact factor: 5.546

3.  Local molecular and global connectomic contributions to cross-disorder cortical abnormalities.

Authors:  Justine Y Hansen; Golia Shafiei; Jacob W Vogel; Kelly Smart; Carrie E Bearden; Martine Hoogman; Barbara Franke; Daan van Rooij; Jan Buitelaar; Carrie R McDonald; Sanjay M Sisodiya; Lianne Schmaal; Dick J Veltman; Odile A van den Heuvel; Dan J Stein; Theo G M van Erp; Christopher R K Ching; Ole A Andreassen; Tomas Hajek; Nils Opel; Gemma Modinos; André Aleman; Ysbrand van der Werf; Neda Jahanshad; Sophia I Thomopoulos; Paul M Thompson; Richard E Carson; Alain Dagher; Bratislav Misic
Journal:  Nat Commun       Date:  2022-08-10       Impact factor: 17.694

4.  Effect of whole body cryotherapy on low back pain and release of endorphins and stress hormones in patients with lumbar spine osteoarthritis.

Authors:  Marta Barłowska-Trybulec; Klaudia Zawojska; Joanna Szklarczyk; Marta Góralska
Journal:  Reumatologia       Date:  2022-09-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.